Pitfalls and Progress in the Diagnosis and Management of Canine Inflammatory Bowel Disease

Veterinary Clinics of North America - Small Animal Practice

Volumn 41, Issue 2, 2011, Pages 381-398

  Simpson, Kenneth W ^a   Jergens, Albert E ^b  

^a Department of Obstetrics Gynecology   (United States)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

Bacteria; Diet; Enteropathy; Inflammatory bowel disease

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; DEXAMETHASONE; FENBENDAZOLE; FUROSEMIDE; GLUCOCORTICOID; METRONIDAZOLE; OXYTETRACYCLINE; PREDNISOLONE; SPIRONOLACTONE; TYLOSIN;

ASCITES; CELL INFILTRATION; CROHN DISEASE; CYTOKINE PRODUCTION; DIAGNOSTIC IMAGING; DIARRHEA; DIETARY INTAKE; DISEASE SEVERITY; DOG; DRUG DOSE REDUCTION; EDEMA; ENTERITIS; ENTEROPATHY; EOSINOPHILIC ENTERITIS; FLUORESCENCE IN SITU HYBRIDIZATION; GASTROINTESTINAL SYMPTOM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GIARDIASIS; HETEROZYGOSITY; HISTOPATHOLOGY; IMMUNE SYSTEM; INNATE IMMUNITY; INTESTINE BIOPSY; INTESTINE FLORA; LYMPHANGIECTASIS; NONHUMAN; PHENOTYPE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE DISTRIBUTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DIAGNOSIS, DIFFERENTIAL; DIET; DOG DISEASES; DOGS; GENETIC PREDISPOSITION TO DISEASE; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

CANIS FAMILIARIS;

EID: 79953883600     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvsm.2011.02.003     Document Type: Review

References (59)

1. Packey C.D., Sartor R.B. Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases. J Intern Med 2008, 263(6):597-606.
2. Perez L.H., Butler M., Creasey T., et al. Direct bacterial killing in vitro by recombinant Nod2 is compromised by Crohn's disease-associated mutations. PLoS One 2010, 5(6):e10915.
3. Batt R.M., McLean L., Riley J.E. Response of the jejunal mucosa of dogs with aerobic and anaerobic bacterial overgrowth to antibiotic therapy. Gut 1988, 29(4):473-482.
4. German A.J., Day M.J., Ruaux C.G., et al. Comparison of direct and indirect tests for small intestinal bacterial overgrowth and antibiotic-responsive diarrhea in dogs. J Vet Intern Med 2003, 17(1):33-43.
5. Simpson K.W., Dogan B., Rishniw M., et al. Adherent and invasive Escherichia coli is associated with granulomatous colitis in boxer dogs. Infect Immun 2006, 74(8):4778-4792.
6. Westermarck E., Skrzypczak T., Harmoinen J., et al. Tylosin-responsive chronic diarrhea in dogs. J Vet Intern Med 2005, 19(2):177-186.
7. Baumgart M., Dogan B., Rishniw M., et al. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. ISME J 2007, 1(5):403-418.
8. Mansfield C.S., James F.E., Craven M., et al. Remission of histiocytic ulcerative colitis in Boxer dogs correlates with eradication of invasive intramucosal Escherichia coli. J Vet Intern Med 2009, 23(5):964-969.
9. Craven M. Genome wide analysis of granulomatous colitis in Boxer dogs 2010, ACVIM, Anaheim (CA).
10. Allenspach K., House A., Smith K., et al. Evaluation of mucosal bacteria and histopathology, clinical disease activity and expression of Toll-like receptors in German shepherd dogs with chronic enteropathies. Vet Microbiol 2010, 146(3-4):326-335.
11. Kathrani A. Overdominant Single Nucleotide Polymorphisms in the Nucleotide Oligomerisation Domain Two (NOD2) Gene are Significantly Associated With Canine Inflammatory Bowel Disease. Proceedings of the ACVIM symposium. Anaheim (CA): ACVIM; 2010. p. 176.
12. Trynka G., Wijmenga C., van Heel D.A. A genetic perspective on coeliac disease. Trends Mol Med 2010, 16(11):537-550.
13. Garden O.A., Pidduck H., Lakhani K.H., et al. Inheritance of gluten-sensitive enteropathy in Irish Setters. Am J Vet Res 2000, 61(4):462-468.
14. Vaden S.L., Hammerberg B., Davenport D.J., et al. Food hypersensitivity reactions in Soft Coated Wheaten Terriers with protein-losing enteropathy or protein-losing nephropathy or both: gastroscopic food sensitivity testing, dietary provocation, and fecal immunoglobulin E. J Vet Intern Med 2000, 14(1):60-67.
15. Littman M.P., Dambach D.M., Vaden S.L., et al. Familial protein-losing enteropathy and protein-losing nephropathy in Soft Coated Wheaten Terriers: 222 cases (1983-1997). J Vet Intern Med 2000, 14(1):68-80.
16. Anand V., Russell A.S., Tsuyuki R., et al. Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies as serological markers are not specific in the identification of Crohn's disease and ulcerative colitis. Can J Gastroenterol 2008, 22(1):33-36.
17. Allenspach K., Lomas B., Wieland B., et al. Evaluation of perinuclear anti-neutrophilic cytoplasmic autoantibodies as an early marker of protein-losing enteropathy and protein-losing nephropathy in Soft Coated Wheaten Terriers. Am J Vet Res 2008, 69(10):1301-1304.
18. Luckschander N., Allenspach K., Hall J., et al. Perinuclear antineutrophilic cytoplasmic antibody and response to treatment in diarrheic dogs with food responsive disease or inflammatory bowel disease. J Vet Intern Med 2006, 20(2):221-227.
19. Mancho C., Sainz A., García-Sancho M., et al. Detection of perinuclear antineutrophil cytoplasmic antibodies and antinuclear antibodies in the diagnosis of canine inflammatory bowel disease. J Vet Diagn Invest 2010, 22(4):553-558.
20. Grützner N., Bishop M.A., Suchodolski J.S., et al. Association study of cobalamin deficiency in the Chinese Shar Pei. J Hered 2010, 101(2):211-217.
21. Breitschwerdt E.B., Ochoa R., Barta M., et al. Clinical and laboratory characterization of Basenjis with immunoproliferative small intestinal disease. Am J Vet Res 1984, 45(2):267-273.
22. Kimmel S.E., Waddell L.S., Michel K.E. Hypomagnesemia and hypocalcemia associated with protein-losing enteropathy in Yorkshire terriers: five cases (1992-1998). J Am Vet Med Assoc 2000, 217(5):703-706.
23. Kolbjørnsen O., Press C.M., Landsverk T. Gastropathies in the Lundehund. I. Gastritis and gastric neoplasia associated with intestinal lymphangiectasia. APMIS 1994, 102(9):647-661.
24. Eckburg P.B., Bik E.M., Bernstein C.N., et al. Diversity of the human intestinal microbial flora. Science 2005, 308(5728):1635-1638.
25. Craven M., Dogan B., Schukken A., et al. Antimicrobial resistance impacts clinical outcome of granulomatous colitis in boxer dogs. J Vet Intern Med 2010, 24(4):819-824.
26. Janeczko S., Atwater D., Bogel E., et al. The relationship of mucosal bacteria to duodenal histopathology, cytokine mRNA, and clinical disease activity in cats with inflammatory bowel disease. Vet Microbiol 2008, 128(1-2):178-193.
27. Suchodolski J.S., Xenoulis P.G., Paddock C.G., et al. Molecular analysis of the bacterial microbiota in duodenal biopsies from dogs with idiopathic inflammatory bowel disease. Vet Microbiol 2010, 142(3-4):394-400.
28. Xenoulis P.G., Palculict B., Allenspach K., et al. Molecular-phylogenetic characterization of microbial communities imbalances in the small intestine of dogs with inflammatory bowel disease. FEMS Microbiol Ecol 2008, 66(3):579-589.
29. Suchodolski J.S., Dowd S.E., Westermarck E., et al. The effect of the macrolide antibiotic tylosin on microbial diversity in the canine small intestine as demonstrated by massive parallel 16S rRNA gene sequencing. BMC Microbiol 2009, 9:210.
30. Mandigers P.J., Biourge V., Van Den Ingh T.S., et al. A randomized, open-label, positively-controlled field trial of a hydrolyzed protein diet in dogs with chronic small bowel enteropathy. J Vet Intern Med 2010, 24(6):1350-1357.
31. Craven M., SE Dowd, S McDonough, et al. High throughput pyrosequencing reveals reduced bacterial diversity in the duodenal mucosa of dogs with IBD [abstract #158]. Proceedings of the 2009 ACVIM Congress in Montreal, Canada. J Vet Inter Med 2009, 23(3):731.
32. Guilford W.G., Jones B.R., Markwell P.J., et al. Food sensitivity in cats with chronic idiopathic gastrointestinal problems. J Vet Intern Med 2001, 15(1):7-13.
33. Marks S.L., Laflamme D., McCandlish A. Dietary trial using a commercial hypoallergenic diet containing hydrolyzed protein for dogs with inflammatory bowel disease. Vet Ther 2002, 3:109-118.
34. Bhattacharyya S., Dudeja P.K., Tobacman J.K. Tumor necrosis factor {alpha}-induced inflammation is increased and apoptosis is inhibited by common food additive carrageenan. J Biol Chem 2010, 285(50):39511-39522.
35. Jergens A.E., Schreiner C.A., Frank D.E., et al. A scoring index for disease activity in canine inflammatory bowel disease. J Vet Intern Med 2003, 7(3):291-297.
36. Allenspach K., Wieland B., Gröne A., et al. Chronic enteropathies in dogs: evaluation of risk factors for negative outcome. J Vet Intern Med 2007, 21(4):700-708.
37. Craven M., Duhammel G., NB Sutter, et al. Absence of a bacterial association in Yorkshire terriers with protein-losing enteropathy and cystic intestinal crypts. Proceedings of the 2009 ACVIM Congress in Montreal, Canada. Vet Inter Med 2009, 23(3):757.
38. Willard M.D., Mansell J., Fosgate G.T., et al. Effect of sample quality on the sensitivity of endoscopic biopsy for detecting gastric and duodenal lesions in dogs and cats. J Vet Intern Med 2008, 22(5):1084-1089.
39. Wiinberg B., Spohr A., Dietz H.H., et al. Quantitative analysis of inflammatory and immune responses in dogs with gastritis and their relationship to Helicobacter spp. infection. J Vet Intern Med 2005, 19(1):4-14.
40. Kleinschmidt S., Meneses F., Nolte I., et al. Characterization of mast cell numbers and subtypes in biopsies from the gastrointestinal tract of dogs with lymphocytic-plasmacytic or eosinophilic gastroenterocolitis. Vet Immunol Immunopathol 2007, 120(3-4):80-92.
41. Peterson P.B., Willard M.D. Protein-losing enteropathies. Vet Clin North Am Small Anim Pract 2003, 33(5):1061-1082.
42. Schreiner N.M., Gaschen F., Gröne A., et al. Clinical signs, histology, and CD3-positive cells before and after treatment of dogs with chronic enteropathies. J Vet Intern Med 2008, 22(5):1079-1083.
43. Waly N.E., Stokes C.R., Gruffydd-Jones T.J., et al. Immune cell populations in the duodenal mucosa of cats with inflammatory bowel disease. J Vet Intern Med 2004, 18(6):816-825.
44. Roth L., Walton A.M., Leib M.S., et al. A grading system for lymphocytic plasmacytic colitis in dogs. J Vet Diagn Invest 1990, 2(4):257-262.
45. van der Gaag I. The histological appearance of large intestinal biopsies in dogs with clinical signs of large bowel disease. Can J Vet Res 1988, 52(1):75-82.
46. Craven M., Simpson J.W., Ridyard A.E., et al. Canine inflammatory bowel disease: retrospective analysis of diagnosis and outcome in 80 cases (1995-2002). J Small Anim Pract 2004, 45(7):336-342.
47. Willard M.D., Zenger E., Mansell J.L. Protein-losing enteropathy associated with cystic mucoid changes in the intestinal crypts of two dogs. J Am Anim Hosp Assoc 2003, 39(2):187-191.
48. Willard M.D., Jergens A.E., Duncan R.B., et al. Interobserver variation among histopathologic evaluations of intestinal tissues from dogs and cats. J Am Vet Med Assoc 2002, 220(8):1177-1182.
49. Day M.J., Bilzer T., Mansell J., et al. Histopathological standards for the diagnosis of gastrointestinal inflammation in endoscopic biopsy samples from the dog and cat: a report from the World Small Animal Veterinary Association Gastrointestinal Standardization Group. J Comp Pathol 2008, 138(Suppl 1):S1-S43.
50. Willard M.D., Moore G.E., Denton B.D., et al. Effect of tissue processing on assessment of endoscopic intestinal biopsies in dogs and cats. J Vet Intern Med 2010, 24(1):84-89.
51. Simpson K.W. Small intestinal bacterial overgrowth. J Am Vet Med Assoc 1994, 205(3):405-407.
52. Allenspach K., Rüfenacht S., Sauter S., et al. Pharmacokinetics and clinical efficacy of cyclosporine treatment of dogs with steroid-refractory inflammatory bowel disease. J Vet Intern Med 2006, 20(2):239-244.
53. Bush W.W., Kimmel S.E., Wosar M.A., et al. Secondary hypoparathyroidism attributed to hypomagnesemia in a dog with protein-losing enteropathy. J Am Vet Med Assoc 2001, 219(12):1732-1734. 1708.
54. Mellanby R.J., Mellor P.J., Roulois A., et al. Hypocalcaemia associated with low serum vitamin D metabolite concentrations in two dogs with protein-losing enteropathies. J Small Anim Pract 2005, 46(7):345-351.
55. Desai A.P., Guvenc B.H., Carachi R. Evidence for medium chain triglycerides in the treatment of primary intestinal lymphangiectasia. Eur J Pediatr Surg 2009, 19(4):241-245.
56. Dijkstra M., Kraus J.S., Bosje J.T., et al. Tijdschr Diergeneeskd 2010, 135(10):406-412. [in Dutch].
57. Lecoindre P., Chevallier M., Guerret S. Schweiz Arch Tierheilkd 2010, 152(3):141-146. [in French].
58. Tanaka H., Nakayama M., Takase K. Histiocytic ulcerative colitis in a French bulldog. J Vet Med Sci 2003, 65(3):431-433.
59. Gaschen L., Kircher P., Stüssi A., et al. Comparison of ultrasonographic findings with clinical activity index (CIBDAI) and diagnosis in dogs with chronic enteropathies. Vet Radiol Ultrasound 2008, 49(1):56-64.